Abstract
Nanomedicine is a new field of research and industrial development which aims to use nano-objects for therapeutic purposes. Through miniaturisation, labs-on-chips can improve the performance of medical analysis and diagnosis, while biosensors become less invasive, hence better tolerated or implanted. With the development of nanoscale contrast agents, clinical imaging benefits from better resolution. In the field of therapy, nanocarriers can transport medicines right up to the sick tissue within the organism, while metal nanoparticles can be used for localised destruction of tumours. The possibility of combining diagnosis and therapy by means of these nano-objects (theranostics) also offers hope of improving medical practice generally. Likewise, the controlled combination of stem cells and biomaterials should lead to a new form of regenerative medicine, able to regenerate and repair damaged or destroyed tissue in vivo. This chapter deals precisely with these developments made possible by nanomedicine, discussing the relevant ethical problems which arise also for conventional medicine. It ends with a discussion of the industrial prospects, describing some of the many clinical trials now under way and the promise of innovative drugs for the benefit of the patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
It is common practice to refer to the combined system of the nanocarrier and the drug it transports as the nanodrug.
References
www.cnrs.fr/cw/dossiers/dosnano/cine/film/anim/vectoEntier.htm
V. Poher, C.P. Allier, J.G. Coutard, L. Herve, J.M. Dinten, Lens free in-line holographic detection of bacteria, in Advanced Microscopy Techniques II. Proceedings of SPIE, vol. 8086 (2011)
www.understandingnano.com/nanomedicine-nanoparticles-targeted-chemotherapy.html
A.E. Colvin, H. Jiang, Increased in vivo stability and functional lifetime of an implantable glucose sensor through platinum catalysis. J. Biomed. Mater. Res. 101A, 1274–1282 (2013). \(\copyright \) 2013, Wiley
P.D. Rakowska, M.G. Ryadnov, Nano-enabled biomarker discovery and detection. Biomark. Med. 5, 387–96 (2011)
F.J. Picard, M.G. Bergeron, Rapid molecular theranostics in infectious diseases. Drug Discov. Today 7, 1092–1101 (2002)
M.L. Etheridge, S.A. Campbell, A.G. Erdman, L. Haynes, S.M. Wolf, J. McCullough, The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed.: Nanotechnol. Biol. Med. 9, 1–14 (2013)
E. Martinez, E. Engel, J.A. Planell, J. Samitier, Annals of Anatomy (Anatomischer Anzeiger) 191, 126–135 (2009)
http://nanocolors.wordpress.com/2009/03/08/nanoparticles-in-clinical-trials-repartition-by-phases
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Boisseau, P. (2016). Nanomedicine and Nanotechnology for Medicine. In: Lourtioz, JM., Lahmani, M., Dupas-Haeberlin, C., Hesto, P. (eds) Nanosciences and Nanotechnology. Springer, Cham. https://doi.org/10.1007/978-3-319-19360-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-19360-1_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19359-5
Online ISBN: 978-3-319-19360-1
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)